Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000966173 | SCV001113465 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Knight Diagnostic Laboratories, |
RCV000966173 | SCV001449013 | benign | not provided | 2019-05-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000966173 | SCV003917339 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | ZC3H14: BS1, BS2 |
OMIM | RCV000240871 | SCV000299369 | pathogenic | Intellectual disability, autosomal recessive 56 | 2021-12-02 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000240871 | SCV001142443 | benign | Intellectual disability, autosomal recessive 56 | 2020-01-06 | no assertion criteria provided | curation | NG_050601.1(NM_024824.4):c.2204+17_2204+41del in ZC3H14 gene has an allele frequency of 0.028 in Ashkenazi Jewish subpopulation in the gnomAD database, including 22 homozygous occurrences. Benign computational verdict because benign prediction from GERP. Pak et al. reported three intellectual disability patients in a consanguineous family with the homozygous of this deletion. Haplotype of the single linkage interval with maximum LOD score of 2.5 in Family-2 (PMID: 21734151). Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1, BS2, BP4, PM3_Supporting, PP1_Strong. |